BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36042051)

  • 1. Clinical significance of cytomegalovirus (CMV) pp65 antigenemia in the prediction of CMV infection during immunosuppressive therapy for rheumatic disease.
    Suga K; Nishiwaki A; Nakamura T; Kagami SI
    Rheumatol Int; 2023 Jun; 43(6):1093-1099. PubMed ID: 36042051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study.
    Ogata H; Aoki N; Nagano K; Hakamata M; Bamba Y; Shibata S; Koizumi T; Ohshima Y; Watanabe S; Moro H; Koya T; Kikuchi T
    J Infect Chemother; 2022 Nov; 28(11):1471-1477. PubMed ID: 35850402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.
    Sénéchal M; Dorent R; du Montcel ST; Fillet AM; Ghossoub JJ; Dubois M; Pavie A; Gandjbakhch I
    Clin Transplant; 2003 Oct; 17(5):423-7. PubMed ID: 14703924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
    Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
    Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients.
    Hamada Y; Nagata N; Shimbo T; Igari T; Nakashima R; Asayama N; Nishimura S; Yazaki H; Teruya K; Gatanaga H; Kikuchi Y; Akiyama J; Ohmagari N; Uemura N; Oka S
    AIDS Patient Care STDS; 2013 Jul; 27(7):387-91. PubMed ID: 23799239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients.
    Nagata N; Kobayakawa M; Shimbo T; Hoshimoto K; Yada T; Gotoda T; Akiyama J; Oka S; Uemura N
    World J Gastroenterol; 2011 Mar; 17(9):1185-91. PubMed ID: 21448424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of flow cytometry to detect PP65 antigenemia for diagnosis and monitoring of human cytomegalovirus infection].
    Wei J; Tang YM; Zheng JY; Zhang CM; Wang YE; Shen HQ; Qian BQ
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):13-7. PubMed ID: 15796798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical features of cytomegalovirus infection diagnosed by cytomegalovirus pp65 antigenemia assay during high dose corticosteroid therapy for collagen vascular diseases.
    Yamashita M; Ishii T; Iwama N; Takahashi H
    Clin Exp Rheumatol; 2006; 24(6):649-55. PubMed ID: 17207380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease.
    Kaneshita S; Kida T; Yokota I; Nagahara H; Seno T; Wada M; Kohno M; Kawahito Y
    Mod Rheumatol; 2020 Jan; 30(1):109-115. PubMed ID: 30472908
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
    Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
    Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus Pneumonia in Patients with Rheumatic Diseases After Immunosuppressive Therapy: A Single Center Study in China.
    Xue Y; Jiang L; Wan WG; Chen YM; Zhang J; Zhang ZC
    Chin Med J (Engl); 2016 Feb; 129(3):267-73. PubMed ID: 26831226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of cytomegalovirus antigenemia predicts serious infection and death in patients receiving immunosuppressive therapies for autoimmune diseases.
    Yoshihara R; Komai T; Shoda H; Fujio K
    Int J Rheum Dis; 2020 Nov; 23(11):1534-1540. PubMed ID: 33051990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.
    Capria S; Gentile G; Capobianchi A; Cardarelli L; Gianfelici V; Trisolini SM; Foà R; Martino P; Meloni G
    J Med Virol; 2010 Jul; 82(7):1201-7. PubMed ID: 20513085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
    Boeckh M; Gooley TA; Myerson D; Cunningham T; Schoch G; Bowden RA
    Blood; 1996 Nov; 88(10):4063-71. PubMed ID: 8916975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients.
    Niubò J; Pérez JL; Martínez-Lacasa JT; García A; Roca J; Fabregat J; Gil-Vernet S; Martín R
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):19-24. PubMed ID: 8988759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.